Krukar, K. M. (2024) “Clinical use of Abemaciclib a cyclin-dependent kinase (CDK) 4/6 inhibitor in patients with breast cancer — literature review”, Journal of Education, Health and Sport, 68, p. 55282. doi: 10.12775/JEHS.2024.68.55282.